These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17143010)

  • 1. Incidence and predictors of development of acute renal failure related to treatment of congestive heart failure with ACE inhibitors.
    Cruz CS; Cruz LS; Silva GR; Marcílio de Souza CA
    Nephron Clin Pract; 2007; 105(2):c77-83. PubMed ID: 17143010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS; Cruz AA; Marcílio de Souza CA
    Nephrol Dial Transplant; 2003 Sep; 18(9):1814-9. PubMed ID: 12937229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE; Cohen J; Vivera M; Zaltzman JS
    Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors associated with hyperkalemia in patients with congestive heart failure.
    Ramadan FH; Masoodi N; El-Solh AA
    J Clin Pharm Ther; 2005 Jun; 30(3):233-9. PubMed ID: 15896240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
    de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
    Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
    Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D
    J Card Fail; 2004 Aug; 10(4):297-303. PubMed ID: 15309695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK; Markert RJ; Saklayen MG; Mankus RA; Yokokawa K
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome.
    Ueno H; Yoshimura M; Nakayama M; Yamamuro M; Nishijima T; Kusuhara K; Nagayoshi Y; Kojima S; Kaikita K; Sumida H; Sugiyama S; Ogawa H
    Int J Cardiol; 2010 Jan; 138(2):174-81. PubMed ID: 18804879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure.
    Chittineni H; Miyawaki N; Gulipelli S; Fishbane S
    Am J Nephrol; 2007; 27(1):55-62. PubMed ID: 17259694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].
    Grigorian Shamagian L; Varela Román A; Pedreira Pérez M; Gómez Otero I; Virgós Lamela A; González-Juanatey JR
    Rev Esp Cardiol; 2006 Feb; 59(2):99-108. PubMed ID: 16540030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide).
    Iglesias J; Hom D; Antoniotti M; Ayoub S; Levine JS
    Nephrol Dial Transplant; 2006 Dec; 21(12):3458-65. PubMed ID: 16877484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events.
    Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Follath F
    J Pharmacol Exp Ther; 1999 Apr; 289(1):565-71. PubMed ID: 10087051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.